Organization: Health Canada
Year: 2022
Month: July
Request Number: A-2022-000055
Request Summary: Adverse Drug Reactions (ADRs) for Dexilant. Report numbers: E2B_05049733, E2B_05027959, E2B_04997641. ADRs for ENTYVIO. Report numbers: E2B_04988450, E2B_05037027, E2B_05010527, 000979424. ADR for Vedolizumab. Report number: E2B_05079036. ADR for Ixazomib. Report number: E2B_05011569. ADR for Ondansetron. Report number: E2B_04998974.
Disposition: Disclosed in part
Number of pages: 254